These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16969646)

  • 1. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients.
    Lindholm E; Bakhtadze E; Sjögren M; Cilio CM; Agardh E; Groop L; Agardh CD
    Diabetologia; 2006 Nov; 49(11):2745-55. PubMed ID: 16969646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients.
    Yoshioka K; Yoshida T; Takakura Y; Umekawa T; Kogure A; Toda H; Yoshikawa T
    Intern Med; 2005 May; 44(5):417-21. PubMed ID: 15942086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients.
    Matsunaga-Irie S; Maruyama T; Yamamoto Y; Motohashi Y; Hirose H; Shimada A; Murata M; Saruta T
    Diabetes Care; 2004 Feb; 27(2):303-7. PubMed ID: 14747204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients.
    Agardh E; Gaur LK; Lernmark A; Agardh CD
    J Diabetes Complications; 2004; 18(1):32-6. PubMed ID: 15019597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between LTA, TNF and AGER polymorphisms and late diabetic complications.
    Lindholm E; Bakhtadze E; Cilio C; Agardh E; Groop L; Agardh CD
    PLoS One; 2008 Jun; 3(6):e2546. PubMed ID: 18575614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The codon 17 polymorphism of the CTLA4 gene in type 2 diabetes mellitus.
    Rau H; Braun J; Donner H; Seissler J; Siegmund T; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 2001 Feb; 86(2):653-5. PubMed ID: 11158025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes.
    Prevost G; Fajardy I; Fontaine P; Danze PM; Besmond C
    Eur J Immunogenet; 1999 Oct; 26(5):343-8. PubMed ID: 10553500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients.
    Qayyum S; Afzal M; Naveed AK
    J Pak Med Assoc; 2021 Apr; 71(4):1175-1180. PubMed ID: 34125766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.
    Laki J; Kiszel P; Vatay A; Blaskó B; Kovács M; Körner A; Madácsy L; Blatniczky L; Almássy Z; Szalai C; Rajczy K; Pozsonyi E; Karádi I; Fazakas A; Hosszúfalusi N; Pánczél P; Arason GJ; Wu YL; Zhou B; Yang Y; Yu CY; Füst G
    Mol Immunol; 2007 Jan; 44(4):648-55. PubMed ID: 16504296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.
    Prevost G; Fajardy I; Besmond C; Balkau B; Tichet J; Fontaine P; Danze PM; Marre M;
    Diabetes Metab; 2005 Feb; 31(1):35-9. PubMed ID: 15803111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQB1 subtypes predict diabetic retinopathy in patients with type I diabetes mellitus.
    Khazaee MH; Tavakol Afshari J; Khazaee B; Daneshvar R; Akbarzadeh J; Khazaee L; Ganjali R; Raygan F
    Eur J Ophthalmol; 2009; 19(4):638-45. PubMed ID: 19551681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RAGE (p.Gly82Ser) and MnSOD (p.Val16Ala) polymorphisms with diabetic retinopathy in T2DM patients from north India.
    Vanita V
    Diabetes Res Clin Pract; 2014 Apr; 104(1):155-62. PubMed ID: 24529564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.
    Zhang HM; Chen LL; Wang L; Liao YF; Wu ZH; Ye F; Xu S; Yi LL
    J Endocrinol Invest; 2009 Mar; 32(3):258-62. PubMed ID: 19542745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study.
    Massin P; Dubois-Laforgue D; Meas T; Laloi-Michelin M; Gin H; Bauduceau B; Bellanné-Chantelot C; Bertin E; Blickle JF; Bouhanick B; Cahen-Varsaux J; Casanova S; Charpentier G; Chedin P; Dupuy O; Grimaldi A; Guerci B; Kaloustian E; Lecleire-Collet A; Lorenzini F; Murat A; Narbonne H; Olivier F; Paquis-Flucklinger V; Virally M; Vincenot M; Vialettes B; Timsit J; Guillausseau PJ;
    Diabetologia; 2008 Sep; 51(9):1664-70. PubMed ID: 18581092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes.
    Globocnik Petrovic M; Steblovnik K; Peterlin B; Petrovic D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):873-6. PubMed ID: 14704946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients.
    Kumaramanickavel G; Ramprasad VL; Sripriya S; Upadyay NK; Paul PG; Sharma T
    J Diabetes Complications; 2002; 16(6):391-4. PubMed ID: 12477623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.
    Wang Y; Ng MC; Lee SC; So WY; Tong PC; Cockram CS; Critchley JA; Chan JC
    Diabetes Care; 2003 Aug; 26(8):2410-5. PubMed ID: 12882871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy.
    Kang P; Tian C; Jia C
    Gene; 2012 May; 500(1):1-9. PubMed ID: 22475522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.